Sea Crest Wealth Management, LLC Intellia Therapeutics, Inc. Transaction History

Sea Crest Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$13.88 - $18.41 $5,552 - $7,364	-400 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$12.79 - $17.62 $12,790 - $17,620	-1,000 Reduced 71.43%	400 $7,000
Q4 2018 Feb 13, 2019	SELL	$11.39 - $27.13 $2,278 - $5,426	-200 Reduced 12.5%	1,400 $19,000
Q3 2018 Nov 14, 2018	BUY	$25.78 - $32.6 $5,413 - $6,846	210 Added 15.11%	1,600 $46,000
Q2 2018 Aug 03, 2018	BUY	$20.02 - $30.79 $26,726 - $41,104	1,335 Added 2427.27%	1,390 $38,000
Q1 2018 Apr 20, 2018	BUY	$19.43 - $34.95 $1,068 - $1,922	55 New	55 $1,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.